Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Alessia Capone

3PUBLICATIONS
31CO-AUTHORS
Innate immunityMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Mar 20, 2024
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses.

Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno

|Nov 07, 2020
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.

Valentina Panzeri, Isabella Manni, Alessia Capone

|Jun 07, 2019
Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients.

Alessia Capone, Manuela Bianco, Gabriella Ruocco

Pageof 1

Frequent Collaborators

1 joint publications

Luca Battistini

1 joint publications

Elisabetta Volpe

1 joint publications

Valentina Panzeri

1 joint publications

Isabella Manni

1 joint publications

Chiara Naro

1 joint publications

Andrea Sacconi

1 joint publications

Silvia Di Agostino

1 joint publications

Luisa de Latouliere

1 joint publications

Andrea Montori

1 joint publications

Emanuela Pilozzi

Frequent Collaborators

1 joint publications

Luca Battistini

1 joint publications

Elisabetta Volpe

1 joint publications

Valentina Panzeri

1 joint publications

Isabella Manni

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.5K
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

3.0K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on : Jul 19, 2019

12.0K
See more related videos

Top Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

9.5K
Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on : Aug 02, 2024

3.0K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on : Jul 19, 2019

12.0K
See more related videos